UNIGE document Scientific Article
previous document  unige:94322  next document
add to browser collection

Impact of rivaroxaban on point-of-care assays

Alberio, Lorenzo
Angelillo-Scherrer, Anne
Korte, Wolfgang
Mendez, Adriana
Schmid, Pirmin
Stricker, Hans
show hidden authors show all authors [1 - 12]
Published in Thrombosis Research. 2017, vol. 153, p. 65-70
Abstract Point-of-care testing (POCT) is regularly used to assess haemostasis in various clinical settings. The impact of rivaroxaban on those POCT is still elusive. We aimed to study the effects of rivaroxaban on most commonly used POCT assays.
PMID: 28343143
Full text
Article (Published version) (473 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Geneva Platelet Group (13)
(ISO format)
FONTANA, Pierre et al. Impact of rivaroxaban on point-of-care assays. In: Thrombosis Research, 2017, vol. 153, p. 65-70. doi: 10.1016/j.thromres.2017.03.019 https://archive-ouverte.unige.ch/unige:94322

312 hits

0 download


Deposited on : 2017-05-16

Export document
Format :
Citation style :